Breakthrough in Regenerative Medicine: Lab-Grown Ureter Tissue from Stem Cells Signals Potential for Transplantable Kidneys

Researchers have engineered functional ureter tissue from human pluripotent stem cells, a significant advancement towards transplantable kidneys. This innovative work addresses previous limitations in kidney organoid development and opens new avenues in regenerative medicine.
Scientists at Kumamoto University have achieved a significant milestone in regenerative medicine by engineering functional ureter tissue from pluripotent stem cells. Published in Nature Communications, this pioneering work successfully produced ureteral organoids that mimic the urinary tract structure, a crucial step towards creating fully functional, transplantable kidneys.
The ureter, a key conduit for urine flow from the kidney to the bladder, has historically been absent from lab-grown kidney models, limiting their ability to replicate complete organ functions. Addressing this challenge, the team led by Professor Ryuichi Nishinakamura utilized induced ureteral stromal progenitors and ureteral epithelial components derived from mouse embryos or induced from human pluripotent stem cells. When combined, these cell types self-organized into layered, contractile ureteral structures, some exhibiting rhythmic peristaltic movements akin to natural urine transport.
Furthermore, the researchers modeled congenital urinary tract disorders by introducing TBX18 mutations, resulting in impaired tissue formation. This approach provides a valuable platform for studying developmental abnormalities and genetic diseases affecting the urinary system.
Professor Nishinakamura emphasized the novelty of this achievement: "This is the first instance of constructing a ureteral structure entirely from pluripotent stem cells. When integrated with kidney organoids, it paves the way for developing transplantable kidneys capable of urine production and excretion."
This breakthrough exemplifies international collaborative efforts aimed at advancing regenerative therapies. The development not only promises potential clinical applications but also contributes to nurturing the next generation of scientists passionate about innovative medical research.
For more details, refer to the original publication: Yutaro Ibi et al., In vitro generation of a ureteral organoid from pluripotent stem cells, Nature Communications (2025). Source: Kumamoto University.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How the Placebo Effect Influences Pain Relief Through the Brain
Recent advancements reveal how the placebo effect activates brain circuits to reduce pain, highlighting the role of endogenous opioids and neural pathways for potential new pain management strategies.
Study Highlights Underestimation of Tick Risks in Southern Norway
New research shows many in southern Norway underestimate the risks of tick bites and related diseases. Awareness and prevention are key to health and safety.
Chickenpox Vaccination Policies: UK Approves the MMRV for Under-Fours Amid US Restrictions
The UK and US adopt contrasting policies on chickenpox vaccination for young children, with the UK approving the MMRV vaccine to enhance coverage, while the US restricts its use due to safety concerns. Learn about the implications for public health and childhood immunity.
Advancing Breast Cancer Support: The Need for Smarter and More Inclusive Mobile Apps
A recent study underscores the urgent need for smarter, more inclusive breast cancer management apps that integrate essential features like mental health support, clinical communication, and AI-driven tools to enhance patient care.



